CircR-DENND2D down-regulates miR-130b-3p to promote STK11 expression, leading to enhancement of CD8+ T cells activity, inhibition of tumor immune escape, and reduction of anti-PD-1/PD-L1 inhibitor resistance in NSCLC [134]. The gene discussed is CD8A; the disease is neoplasm.